Early Detection and Early Treatment in Heart Failure
Official title: Early Detection and IntervenTion in Heart Failure
Run by University Hospital, Basel, Switzerland · NCT07731490 · Data updated 2026-11-12
A bundled approach tests whether increasing awareness and using a simple NT-proBNP blood test can help detect heart failure earlier and reduce hospitalizations for people 65 and older who are having certain heart procedures or high-risk situations.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 18000 (estimated) |
| Sponsor | University Hospital, Basel, Switzerland Academic / other |
| Locations | 21 sites (Vienna and 20 other locations) |
| Status | Recruiting |
| Started | December 3, 2025 |
| Main results expected | April 2028 |
| Study ends | April 2030 |
| Registry record updated | July 28, 2026 |
| Trial ID | NCT07731490 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 65 or older undergoing selected cardiac procedures or presenting with tachyarrhythmias and no prior diagnosed heart failure, who meet local eligibility criteria.
✕Probably not a fit
Patients with established heart failure, renal impairment (eGFR <30), certain cancers, or non-residency in the country of the recruiting site may not benefit from this strategy.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study tests a combined strategy to detect heart failure earlier and start treatment sooner in adults aged 65 and older undergoing specific cardiac procedures or presenting to the emergency department with tachyarrhythmias. The strategy includes raising awareness among patients and clinicians, implementing NT-proBNP testing for early diagnosis, and initiating timely treatment to improve outcomes. The trial assesses whether this approach can lower hospitalization rates related to heart failure and slow disease progression. Enrollment is limited to participants meeting specific eligibility criteria and excludes those with established heart failure, certain comorbidities, or non-residence in the recruiting country. Primary sponsor is University Hospital Basel, with international sites in Vienna, Sofia, and Freiburg.
Why it matters
Potential benefit: If successful, patients may experience earlier diagnosis and treatment of heart failure, potentially reducing hospitalizations and slowing disease progression.
How similar studies have gone: Prior studies indicate substantial undetected heart failure in high-risk populations, suggesting potential benefit from proactive screening and early treatment strategies, though this exact bundled approach is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * General consent (GC) has not been rejected. * Age ≥ 65 years. * Elective percutaneous coronary intervention\* (PCI), pulmonary vein isolation\* (PVI), pacemaker implantation\* (PM, no cardiac resynchronisation), transcatheter aortic valve intervention\* (TAVI), major non-cardiac surgery\* or presenting with tachyarrhythmia to the emergency department (ED) (without a diagnosis of HF within 24h). * Exclusion criteria are assessed on day 1 after the procedure Exclusion Criteria: * Systolic blood pressure ≤ 95 mmHg * Estimated glomerular filtration rate (GFR) \<30 mL/min/1.73 m2. * Dementia documented in the medical history. * Metastatic cancer in the medical history. * Previously enrolled in this study. * Known HF. * Known allergies, hypersensitivity, or intolerance to SGLT2 Inhibitors / Loop Diuretics / MRA or is excipients. * Non-resident in the country of the recruiting site * Incapacity of the patient to make judgements * Patients not hospitalized overnight * Patients requiring intensive care unit (ICU) or intermediate care (IMC) stay beyond 11:00 a.m. on the first postoperative day or any post-interventional stroke unit stay until 8:00 a.m. on the first postoperative day. * Patients died prior to postinterventional day 1 (8:00 a.m.) * Severe aortic or mitral stenosis
Where it's running
-
Konkuk University Medical Center
Seoul, South Korea Recruiting -
University Hospital Basel
Basel, Basel, Switzerland Recruiting -
Universitätsklinik für Innere Medizin II
Vienna, Austria Not yet recruiting -
Queen Giovanna University Hospital
Sofia, Bulgaria Not yet recruiting -
University Hospital Freiburg-Bad Krozingen
Freiburg im Breisgau, Germany Not yet recruiting -
Universitätsklinikum der Ruhr-Universität Bochum
Herne, Germany Not yet recruiting
Show 15 more locations
-
Herzzentrum Leipzig, Klinik für Innere Medizin/Kardiologie
Leipzig, Germany Not yet recruiting -
University Hospital Pisa
Pisa, Italy Not yet recruiting -
Erasmus MC Rotterdam
Rotterdam, Netherlands Not yet recruiting -
University Hospital Ramón y Cajal Madrid
Madrid, Spain Not yet recruiting -
University Hospital Lausanne
Lausanne, Lausanne, Switzerland Not yet recruiting -
KSA Kantonsspital Aarau
Aarau, Switzerland Not yet recruiting -
Cantonal Hospital Baden
Baden, Switzerland Not yet recruiting -
St. Claraspital AG
Basel, Switzerland Not yet recruiting -
University Hospital Genève
Geneva, Switzerland Not yet recruiting -
Kantonsspital Luzern
Lucerne, Switzerland Not yet recruiting -
Hospital Istituto Cardiocentro Ticino
Lugano, Switzerland Not yet recruiting -
Kantonsspital St. Gallen
Sankt Gallen, Switzerland Not yet recruiting -
Stadtspital Zürich
Zurich, Switzerland Not yet recruiting -
University Hospital Zurich
Zurich, Switzerland Not yet recruiting -
Royal Infirmary Edinburgh
Edinburgh, United Kingdom Not yet recruiting
Study contacts
- Study coordinator: Christian Müller, Prof. Dr.
- Email: Christian.Mueller@usb.ch
- Phone: +41 61 328 65 49
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Non-Invasive Heart Failure Monitoring in Hospitalized Patients
This study tests whether daily non-invasive thoracic measurements from the Acorai Device 1.0 can relate to health outcomes for adults hospitalized with heart failure.
-
New ways to estimate left heart pressures in people with heart failure and atrial fibrillation
This study tests a new approach that combines ultrasound and clinical data to see if doctors can better tell when the heart’s filling pressure is high in patients who have both heart failure and atrial fibrillation.
-
Left bundle branch pacing plus ICD for people with hypertrophic cardiomyopathy after myectomy
This study will test whether adding left bundle branch pacing to a dual‑chamber ICD helps people with hypertrophic cardiomyopathy who develop left bundle branch block after myectomy to slow heart failure progression and prevent life‑threatening arrhythmias.
-
Home-based Tai Chi program for heart failure patients and their caregivers
This study is testing whether a home-based Tai Chi program can help heart failure patients feel better and make it easier for their caregivers to support them.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.